Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.62−0.29 (-0.09%)
Close on Nov 16, 2026Market cap $12.64BP/E 80.8Yield –
Penumbra ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Penumbra's ebitda for the twelve months ending Sep 30, 2026 was $209.36M, up 10.1% year over year. For fiscal 2025 it was $206.72M, up 526.8% from the year before. Over ten years it grew 42.6% a year on average. The highest annual figure on record is $206.72M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $206.72M | +526.8% |
| FY2024 | Dec 31, 2024 | $32.98M | -67.3% |
| FY2023 | Dec 31, 2023 | $100.81M | +231.6% |
| FY2022 | Dec 31, 2022 | $30.40M | +241.3% |
| FY2021 | Dec 31, 2021 | $8.91M | – |
| FY2020 | Dec 31, 2020 | -$26.05M | -146.8% |
| FY2019 | Dec 31, 2019 | $55.61M | +946.1% |
| FY2018 | Dec 31, 2018 | $5.32M | +7.5% |
| FY2017 | Dec 31, 2017 | $4.95M | +422.3% |
| FY2016 | Dec 31, 2016 | $947.00K | -84.0% |
| FY2015 | Dec 31, 2015 | $5.93M | +57.7% |
| FY2014 | Dec 31, 2014 | $3.76M | – |
| FY2013 | Dec 31, 2013 | -$449.00K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $56.21M | +9.5% |
| Q2 FY2026 | Jun 30, 2026 | $46.65M | +0.7% |
| Q1 FY2026 | Mar 31, 2026 | $42.81M | -5.6% |
| Q4 FY2025 | Dec 31, 2025 | $63.69M | +35.1% |
| Q3 FY2025 | Sep 30, 2025 | $51.33M | +29.9% |
| Q2 FY2025 | Jun 30, 2025 | $46.34M | – |
| Q1 FY2025 | Mar 31, 2025 | $45.37M | +131.2% |
| Q4 FY2024 | Dec 31, 2024 | $47.16M | +12.1% |
| Q3 FY2024 | Sep 30, 2024 | $39.51M | +102.0% |
| Q2 FY2024 | Jun 30, 2024 | -$73.31M | -398.0% |
| Q1 FY2024 | Mar 31, 2024 | $19.62M | +34.5% |
| Q4 FY2023 | Dec 31, 2023 | $42.07M | +273.1% |
| Q3 FY2023 | Sep 30, 2023 | $19.56M | +67.8% |
| Q2 FY2023 | Jun 30, 2023 | $24.60M | +324.9% |
| Q1 FY2023 | Mar 31, 2023 | $14.58M | +768.0% |
| Q4 FY2022 | Dec 31, 2022 | $11.27M | – |
| Q3 FY2022 | Sep 30, 2022 | $11.66M | -6.1% |
| Q2 FY2022 | Jun 30, 2022 | $5.79M | -58.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.68M | -90.1% |
| Q4 FY2021 | Dec 31, 2021 | -$34.30M | -2102.6% |
| Q3 FY2021 | Sep 30, 2021 | $12.41M | – |
| Q2 FY2021 | Jun 30, 2021 | $13.86M | – |
| Q1 FY2021 | Mar 31, 2021 | $16.93M | +374.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.71M | -86.7% |
| Q3 FY2020 | Sep 30, 2020 | -$16.82M | -211.9% |
| Q2 FY2020 | Jun 30, 2020 | -$14.52M | -198.5% |
| Q1 FY2020 | Mar 31, 2020 | $3.57M | -72.5% |
| Q4 FY2019 | Dec 31, 2019 | $12.89M | +53.9% |
| Q3 FY2019 | Sep 30, 2019 | $15.03M | – |
| Q2 FY2019 | Jun 30, 2019 | $14.73M | +36.0% |
| Q1 FY2019 | Mar 31, 2019 | $12.96M | +138.0% |
| Q4 FY2018 | Dec 31, 2018 | $8.38M | +65.7% |
| Q3 FY2018 | Sep 30, 2018 | -$19.34M | -1150.4% |
| Q2 FY2018 | Jun 30, 2018 | $10.83M | – |
| Q1 FY2018 | Mar 31, 2018 | $5.44M | – |
| Q4 FY2017 | Dec 31, 2017 | $5.06M | – |
| Q3 FY2017 | Sep 30, 2017 | $1.84M | – |
| Q2 FY2017 | Jun 30, 2017 | -$560.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.39M | – |
| Q4 FY2016 | Dec 31, 2016 | -$664.00K | – |
See a number that looks wrong?